HealthCo Healthcare and Wellness REIT (ASX: HCW) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Healthco Healthcare And Wellness Reit Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $458.78 million
P/E Ratio N/A
Dividend Yield 5.26%
Shares Outstanding 325.38 million
Earnings per share N/A
Dividend per share 0.08
Year To Date Return -34.38%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

HealthCo Healthcare and Wellness REIT (ASX: HCW)
Latest News

man looking through window at sky scraper buildings
Broker Notes

This is the latest ASX 200 sector to be hit by downgrades

It seems there's no safe place to hide from the current volatility.

Read more »

Four business men go into a derfensive position.
Investing Strategies

4 ‘defensive growth’ ASX shares to buy in turbulent times: Wilsons

High inflation, rising interest rates and a war in Europe. The only certainty is more uncertainty.

Read more »

Happy child jumping for joy.
Small Cap Shares

5 profitable small-cap ASX shares to buy right now: Wilsons

With volatility all around the world, experts warn investors to stick with profitability. Here are some smaller businesses that are…

Read more »

red pen and sheet of paper with A plus written on it
Broker Notes

Top broker picks 6 ASX 200 shares with earnings surprise potential

A leading broker picks its top half dozen this reporting season.

Read more »

ASX 200 shares broker downgrade origami paper fortune teller with buy hold sell and dollar sign options
Share Market News

2 ASX shares that top analysts are loving right now

Some of the best analysts have named some ASX shares to buy.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Share Market News

Goldman Sachs just added this ASX healthcare share to its conviction buy list

This healthcare share could be a strong buy..

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
REITs

The HCW (ASX:HCW) share price has gained 15% since the REIT’s IPO

Here's how the healthcare-focused REIT has performed on the ASX so far .

Read more »

Motley Fool Chief Investment Officer Scott Phillips on nine news
Motley Fool Media

Fortescue’s big fall, job ad numbers disappoint and rates in focus. Scott Phillips on Nine’s Late News

Fortescue shareholders, including Twiggy Forrest, are to enjoy a massive payday which explained the fall in the Fortescue share price…

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
29 Jun 2022 $0.0225 0.00% Final 22 Aug 2022
30 Mar 2022 $0.0225 0.00% Interim 20 May 2022
30 Dec 2021 $0.0300 0.00% Interim 25 Feb 2022

HCW ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About HealthCo Healthcare and Wellness REIT

HealthCo Healthcare and Wellness REIT are owning and managing a portfolio of commercial health and wellness real estate assets.

HCW Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
04 Jul 2022 $1.43 $0.03 2.15% 352,834 $1.40 $1.44 $1.38
01 Jul 2022 $1.40 $0.02 1.45% 424,638 $1.38 $1.41 $1.37
30 Jun 2022 $1.38 $-0.04 -2.82% 443,199 $1.40 $1.41 $1.37
29 Jun 2022 $1.42 $-0.12 -7.82% 1,588,859 $1.49 $1.49 $1.37
28 Jun 2022 $1.54 $0.00 0.00% 659,652 $1.50 $1.56 $1.49
27 Jun 2022 $1.53 $0.03 2.01% 779,748 $1.50 $1.53 $1.48
24 Jun 2022 $1.50 $0.05 3.45% 762,177 $1.45 $1.51 $1.44
23 Jun 2022 $1.45 $-0.02 -1.36% 919,576 $1.53 $1.55 $1.44
22 Jun 2022 $1.47 $-0.01 -0.68% 695,740 $1.55 $1.55 $1.46
21 Jun 2022 $1.48 $-0.05 -3.27% 700,867 $1.52 $1.55 $1.45
20 Jun 2022 $1.53 $0.00 0.00% 477,072 $1.53 $1.53 $1.46
17 Jun 2022 $1.53 $0.03 2.00% 449,008 $1.48 $1.53 $1.43
16 Jun 2022 $1.50 $0.00 0.00% 647,499 $1.49 $1.53 $1.47
15 Jun 2022 $1.50 $-0.07 -4.49% 664,238 $1.51 $1.54 $1.47
14 Jun 2022 $1.56 $-0.07 -4.29% 1,607,150 $1.60 $1.60 $1.47
10 Jun 2022 $1.63 $-0.03 -1.81% 694,370 $1.68 $1.68 $1.63
09 Jun 2022 $1.66 $-0.09 -5.17% 2,513,195 $1.73 $1.74 $1.66
08 Jun 2022 $1.74 $0.02 1.17% 630,906 $1.72 $1.76 $1.70
07 Jun 2022 $1.72 $-0.01 -0.58% 513,603 $1.73 $1.75 $1.69

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
15 Jun 2022 Stephanie Lai Buy 64 $95,680
On-market trade.
05 May 2022 David Di Pilla Buy 58 $109,775
On-market trade.
04 May 2022 David Di Pilla Buy 1 $2,039,589
On-market trade.
03 May 2022 David Di Pilla Buy 165 $320,232
On-market trade.
02 May 2022 David Di Pilla Buy 241 $468,651
On-market trade.
29 Apr 2022 David Di Pilla Buy 401 $787,960
On-market trade.
28 Apr 2022 David Di Pilla Buy 192 $375,311
On-market trade.
10 Mar 2022 David Di Pilla Buy 509 $993,537
On-market trade.
03 Mar 2022 David Di Pilla Buy 347 $687,568
On-market trade.
02 Mar 2022 David Di Pilla Buy 70 $133,784
On-market trade.
01 Mar 2022 David Di Pilla Buy 93 $178,134
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Dr Christopher Graham Roberts Non-Executive Director Aug 2021
Dr Roberts has worked in the medical device industry for over 40 years in a number of senior management positions. He was former CEO of Cochlear from 2004 to 2015 and member of the Cochlear Foundation Board. He was founding director and Executive Vice President of ResMed from 1992 to 2003, and a director until November 2017. He has served as Chair of OncoSil Medical Limited, Chair of TEDI London and non-executive director of Clarity Pharmaceuticals Limited and Atmo Biosciences Pty Ltd. He was also a former Chair of Research Australia (2004 to 2010).
Ms Stephanie Lai Non-Executive Director Aug 2021
Ms Lai has over 20 years' experience as a Chartered Accountant and a former M&A partner of Deloitte and KPMG. She also has experience providing due diligence and advisory services, including forecast reviews to listed entities, sovereign wealth funds, wealth managers and private equity. She is currently serves as independent Non-Executive Director of HMC Funds Management Limited (responsible entity of HomeCo Daily Needs REIT), Superloop and Future Generation Investment Company. She is a member of the Association of Corporate Counsel Australia. She is also Chair of Risk Committee of HCW.
Mr David Anthony Di Pilla Non-Executive Director Jul 2021
Mr Di Pilla has over 20 years of experience in investment banking. He is currently Managing Director and Chief Executive Officer of Home Consortium, and Non-Executive Director of HMC Funds Management Limited (responsible entity of HomeCo Daily Needs REIT). He was a founder, director and shareholder of Aurrum. He was a former strategic advisor and Director to operating subsidiaries of the Tenix Group of Companies from 2014 to 2016. From 2004 to 2015, David was Managing Director and Senior Adviser at UBS, Australia and during this time he advised some of Australia's corporations on mergers and acquisitions, debt and equity capital market transactions.
Hon Kelly Megan O'Dwyer Non-Executive Director Aug 2021
The Hon O'Dwyer has experience in across a range of sectors including funds management, superannuation, workplace relations, foreign investment, law and banking. She is currently serves as independent Non-Executive Director of Home Consortium, EQT Holdings Limited and Barrenjoey Capital Partners Group Holdings Pty Ltd. She has served in the Australian Parliament as a Senior Cabinet Minister holding a number of economic portfolios including Minister for Jobs and Industrial Relations; Minister for Revenue and Financial Services; Minister for Small Business; and Assistant Treasurer. She has also served as Minister for Women; as well as Minister Assisting the Prime Minister with the Public Service. She was former member of the Cabinet's Budget Committee (the Expenditure Review Committee). Prior to entering Parliament, he has worked in law, government and finance.
Mr Joseph Carrozzi Non-Executive ChairmanNon-Executive Director Aug 2021
Mr Carrozzi is a partner in the Big 4 professional services firms for over 20 years, commencing with Tax & Legal Leader at Andersens, Regional Managing Partner at EY and then joining PwC in 2005 as National Managing Partner, Markets and Sydney Office. He has served as Chair of the Centenary Institute for Medical Research, Chair of Sydney Harbour Federation Trust and Deputy Chair of the NSW Institute of Sport. He has also served as Governor on the board of Western Sydney University and Board member of Football Australia. He is also member of Risk Committee of HCW.
Ms Natalie Jane Meyenn Non-Executive Director Aug 2021
Ms Meyenn has over 25 years' experience in financial services and investing globally. Previously, she held the roles of CIO and Chair of the Investment Committee for MLC Private Equity. She has worked in Investment Banking (M&A, capital markets and public finance) in New York and Sydney for many years and spent time at the World Bank working in Asia, Africa and the Pacific Islands on microfinance, project finance and climate change impact mitigation strategies. She has also served as director and/or shareholder for a small number of asset management and investment businesses in Europe and Australia, including a carbon neutral asset management platform in Australia. She is also proposed director of the fund manager of the Unlisted Fund. She is also member of Risk Committee of HCW.
Mr Andrew Selim Company SecretaryGeneral Counsel
-
Andrew Selim Company SecretaryGeneral Counsel
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Home Consortium Developments Limited 65,000,010 19.99%
HSBC Custody Nominees (Australia) Limited 47,434,528 14.59%
J P Morgan Nominees Australia Pty Limited 20,259,926 6.23%
National Nominees Limited 19,098,690 5.87%
Citicorp Nominees Pty Limited 17,237,957 5.30%
HSBC Custody Nominees (Australia) Limited A/C 2 12,569,740 3.87%
UBS Nominees Pty Ltd 9,260,226 2.85%
BNP Paribas Noms Pty Ltd (Drp) 4,561,901 1.40%
Netwealth Investments Limited (Wrap Services A/C) 4,441,631 1.37%
BNP Paribas Nominees Pty Ltd (Agency Lending Drp A/C) 3,220,828 0.99%
Warbont Nominees Pty Ltd (Unpaid Entrepot A/C) 2,945,434 0.91%
Custodial Services Limited (Beneficiaries Holding A/C) 1,650,000 0.51%
Seymour Group Pty Ltd 1,650,000 0.51%
Bridgebox Pty Limited (Bridgebox A/C) 1,500,000 0.46%
Sword Equity Investments Pty Ltd 1,375,000 0.42%
Netwealth Investments Limited (Super Services A/C) 1,321,487 0.41%
Goat Properties Pty Ltd 1,250,000 0.38%
BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd (Drp A/C) 1,215,306 0.37%
Premium Capital (Aust) Pty Ltd 1,082,000 0.33%
BNP Paribas Nominees Pty Ltd (Pitcher Partners Drp) 996,010 0.31%
Friday Investments Pty Limited (Goldburg Family Account) 800,000 0.25%

Profile

since

Note